
KVUE • NYSE
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold KVUE in your mock portfolio yet.
With EPS at 0.75 and a PE ratio of 25.17, Kenvue is priced at a moderate premium relative to its current earnings, suggesting the market expects steady but not explosive growth. The valuation appears reasonable for a defensive consumer-health name, but without evidence here of accelerating earnings or margin expansion, the earnings profile looks stable rather than strongly growth-oriented.
The stock is trading at $18.88, slightly below its 200-day moving average of $19.17, which indicates a mildly negative longer-term trend despite a 6.4% gain over the last month. An RSI of 50.61 is firmly neutral, suggesting neither overbought nor oversold conditions and pointing to a consolidating price action.
Alternative data for Kenvue is mixed: hiring and LinkedIn growth are constructive, while Twitter/X engagement is slightly declining and Facebook growth is modest. Web traffic is sizable but without a growth rate provided, it reads as stable rather than a strong positive or negative signal.
Overall, Kenvue’s setup appears neutral: valuation is reasonable for a defensive name, technicals are stabilizing but not strongly bullish, and alternative data shows steady but not explosive engagement and hiring momentum. The stock looks more like a steady, core holding candidate than a high-conviction upside or downside opportunity based on the provided data.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Key moves vs recent baseline (last day / last week)
Plain-English summary of the biggest drivers (informational)
Potential risk factors to review
Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.
Reassess your thesis if any of these occur: